08/30/2024 5:01 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 3:06 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024 3:34 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 5:00 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 3:34 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024 3:36 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 5:00 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/22/2024 3:09 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 5:03 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 5:00 PM | Intra-Cellular Therapies (Issuer) Narula Sanjeev (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2024 5:01 PM | Intra-Cellular Therapies (Issuer) Narula Sanjeev (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 6:55 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024 6:49 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 7:00 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:00 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:04 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:05 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:05 PM | Intra-Cellular Therapies (Issuer) Salas Eduardo Rene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:05 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:28 PM | Intra-Cellular Therapies (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/21/2024 5:00 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 5:00 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 5:01 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 5:02 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 5:02 PM | Intra-Cellular Therapies (Issuer) Salas Eduardo Rene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 6:40 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 6:43 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 3:46 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
04/29/2024 3:48 PM | Intra-Cellular Therapies (Filer)
| Form ARS | |
04/24/2024 3:20 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 4:23 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/18/2024 4:25 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024 6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:15 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 7:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 7:31 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
03/11/2024 7:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:32 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:33 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:52 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:38 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:30 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:58 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:44 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:36 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 3:27 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:04 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:05 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:41 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:57 PM | Intra-Cellular Therapies (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:58 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 6:59 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 7:00 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:22 PM | Intra-Cellular Therapies (Subject) VAN NOSTRAND ROBERT L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:46 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:33 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:22 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:42 AM | Intra-Cellular Therapies (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/09/2024 11:40 AM | Intra-Cellular Therapies (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024 5:02 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:05 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:07 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:10 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:13 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:47 PM | Hineline Lawrence J. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:39 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:41 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 6:47 PM | Intra-Cellular Therapies (Issuer) Mates Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 4:08 PM | Intra-Cellular Therapies (Subject) Mates Sharon (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 5:02 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:45 PM | Halstead Michael (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 6:54 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:43 PM | Intra-Cellular Therapies (Issuer) VAN NOSTRAND ROBERT L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
01/03/2024 5:46 PM | Intra-Cellular Therapies (Issuer) RIGGS RORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:38 PM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 10:15 AM | Durgam Suresh K. (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:52 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 4:31 PM | Intra-Cellular Therapies (Issuer) Neumann Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 3:15 PM | Alexandria Venture Investments, LLC (Reporting) Intra-Cellular Therapies (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023 12:06 PM | Intra-Cellular Therapies (Subject) Neumann Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 7:01 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 7:01 AM | Intra-Cellular Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |